Copyright
©2014 Baishideng Publishing Group Co.
World J Clin Oncol. May 10, 2014; 5(2): 164-169
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.164
Published online May 10, 2014. doi: 10.5306/wjco.v5.i2.164
Drugs on the national market before 1999 | Market placement yr | Drugs on the national market before 1999 | Market placement yr | Drugs on the national market between 1999 and 2010 | Market placement yr |
Aldesleukin | 1992 | Ifosfamide | 1979 | Bleomycin | 2001 |
Amifostine | 1995 | Interferon Alfa-2A | 1998 | Capecitabine | 2001 |
Anastrozole | 1996 | Intravenous vinorelbine | 1993 | Exemestane | 1999 |
Bicalutamide | 1998 | Irinotecan | 1997 | Hydroxyurea | 2001 |
Bleomycin | 1998 | Letrozole | 1997 | Imatinib | 2001 |
Carboplatin | 1989 | Megestrol | 1987 | Ketoconazole | 2002 |
Carmustine | 1983 | Melphalan | 1966 | Leuprorelin | 1999 |
Chlorambucil | 1966 | Mercaptopurine | 1997 | Liposomal Doxorubicin | 2000 |
Cisplatin | 1980 | Methotrexate | 1993 | Oral vinorelbine | 2001 |
Cyclophosphamide | 1960 | Mitomycin | 1984 | Raltitrexed | 2001 |
Cyclosporine | 1990 | Mitoxantrone | 1998 | Temozolomide | 1999 |
Cyproterone | 1994 | Octreotide | 1989 | Trastuzumab | 2000 |
Cytarabine | 1996 | Oxaliplatin | 1993 | Anagrelide | 2004 |
Dacarbazine | 2000 | Paclitaxel | 1997 | Bevacizumab | 2005 |
Dactinomycin | 1980 | Pegylated liposomal doxorubicin | 1996 | Bortezomib | 2004 |
Docetaxel | 1995 | Procarbazine | 1998 | Cetuximab | 2004 |
Doxorubicin | 1998 | Rituximab | 1998 | Erlotinib | 2005 |
Epirubicin | 1992 | Tamoxifen | 1984 | Fulvestrant | 2004 |
Etoposide | 1998 | Tegafur | 1985 | Interleukin 2 | 2005 |
Estramustine | 1982 | Thalidomide | 1961 | Pemetrexed | 2004 |
Fludarabine | 1995 | Topotecan | 1996 | Azacitidine | 2008 |
Fluorouracil | 1997 | Vaccine, Bacillus Calmette-Guerin | 1992 | Lapatinib | 2008 |
Flutamide | 1998 | Vinblastine | 1991 | Sorafenib | 2006 |
Gemcitabine | 1996 | Vincristine | 1993 | Sunitinib | 2006 |
Goserelin | 1998 | Temsirolimus | 2007 | ||
Idarubicin | 1995 | Trabectedin | 2008 |
- Citation: Peixoto V, Faria AL, Gonçalves M, Macedo J, Rego S, Macías E, Magano A, Loureiro M, Araújo A. Evolution of costs of cancer drugs in a Portuguese hospital. World J Clin Oncol 2014; 5(2): 164-169
- URL: https://www.wjgnet.com/2218-4333/full/v5/i2/164.htm
- DOI: https://dx.doi.org/10.5306/wjco.v5.i2.164